Abstract-Thirteen female Rhesus macaques were intramuscularly injected with 90 Sr(NO 3 ) 2 diluted in sodium citrate solution. The biokinetic data from these animals were compared against the predictions of the NCRP 156 wound models combined with the ICRP systemic models. It was observed that the activities measured in plasma of these nonhuman primates (NHPs) were consistently lower than those predicted by the default human biokinetic models. The urinary excretion from the NHPs at times immediately after injection was much greater than that in humans. The fecal excretion rates were found to be in relatively better agreement with humans. Similarly, the activities retained in the skeleton of the NHPs were lower than those in humans. These differences were attributed to the higher calcium diet of the NHPs (0.03 to 0.12 g d −1 kg −1 body weight) compared to that of humans. These observations were consistent with the early animal and human studies that showed the effect of calcium on strontium metabolism, specifically urinary excretion. Strontium is preferentially filtered at a much higher rate in kidneys than calcium because it is less completely bound to protein than is calcium. These differences, along with large inter-animal variability, should be considered when estimating the behavior of strontium in humans from the metabolic data in animals or vice versa. Health Phys. 113(2):122-128; 2017
INTRODUCTION
STRONTIUM (SR) is one of the main sources of radiological environmental contamination due to the releases from worldwide weapon testing, the Mayak plutonium production complex, the Chernobyl accident, and most recently, the Fukushima accident. The biokinetics of strontium has been the subject of extensive studies since it was known to be the most biologically important component of the fallout from nuclear weapon testing (Durbin et al. 1993a) . The data for the biokinetics of strontium, as it is understood today, came from environmental studies, experimental human studies and experimental animal studies. Although a relatively large amount of human data is available on the metabolism of strontium, the modeling process is complicated by the heterogeneity of the data (Leggett et al. 1998) , so the knowledge from animal studies such as beagles has been used to supplement the data on metabolism of strontium at early times after intake (NCRP 1991) . Studies of calcium metabolism in humans have also been used as supporting information on skeletal turnover and bone-restructuring (Leggett et al. 1982 (Leggett et al. , 1998 . Several recent human studies on strontium metabolism (e.g., Nair et al. 2006; Li et al. 2008) have shown reasonable agreement with the model described in ICRP Publications for strontium (ICRP 1993 (ICRP , 1997 , some have suggested improvements to the model by considering both age and gender (e.g., Shagina et al. 2003) , and some have shown considerable differences (e.g., Hollriegl et al. 2007) .
The interest in the biokinetics of strontium continues to grow, one of the reasons being the possibility of 90 Sr as a potential component of a Radiological Dispersal Device (RDD) (Andersson et al. 2009 ). Besides the inhalation pathway, intake via wound-penetrating wounds produced by contaminated sharp objects or surface contamination of an open wound-may also be a potential pathway for internal exposure. Recent studies have therefore focused on the biokinetics via wound pathways (e.g., Emond and Kalinich 2012) . The objective of this paper was to evaluate the biokinetic data obtained from intramuscular (i.m.) injection studies done by P. W. Durbin in nonhuman primates (NHPs) by applying these data to the NCRP 156 wound model (NCRP 2006) coupled with the strontium systemic model. The data were made available through the Lawrence Berkeley National Laboratory (LBNL) to R.A. Guilmette as a bequest from Durbin.
DATA
Beginning in the 1950s, a series of animal experiments was conducted to supplement the data available on the distribution and excretion of some radionuclides in humans (Durbin et al. 1993a and b) . Strontium, in addition to plutonium and americium, became a subject of study because of the concerns regarding the worldwide fallout from weapon testing, its environmental mobility, and its bone-seeking nature. Despite the extensive nature and scope of this study, much of the data was never analyzed until recently (Konzen et al. 2015; Allen et al. 2016; Poudel et al. 2016a, b, and c; Krage et al. 2016 ).
Animals
Early studies had indicated that nonhuman primates may be the most appropriate animals to understand the biokinetics of bone-seeking radionuclides owing to the similarities in skeletal morphology and patterns of growth and aging. Species of the Old World Monkeys of the genus Macaca were used because of their availability and amenability to laboratory conditions. The scope of this paper included 13 animals of M. mulatta species (Rhesus macaques) that were intramuscularly injected with a 90 Sr solution (Table 1 ). The age of these animals was determined from skeletal roentgenograms and dentition, and all animals considered in this paper were adult females (Durbin et al. 1993a ).
Injections
Stock solutions, prepared from dilution of concentrated 90 Sr(NO 3 ) 2 in 2 N HCl to 3,700 kBq mL
, was stored at 4°C until injection. For injections, the required volume was diluted in sodium citrate, and the desired volume of the solution was injected intramuscularly into the thickest part of the thighs via a glass syringe. The quantity of injection was determined by measurement of total beta activity with a thinwindow GM counter, measurement of bremsstrahlung with a pair of NaI detectors, and measurement of separated 90 Y progeny (Durbin et al. 1993a ). The injected amount ranged from approximately 135 kBq to 1,935 kBq (dosages ranging from 23 to 515 kBq kg −1 body weight).
Samples
The data for the 90 Sr content in urine and fecal samples are available intermittently until 25 d after i.m. injection. To understand the clearance from plasma, blood samples were also drawn from the superficial leg veins into lightly heparinized syringes. The animals were sacrificed between 8 and 5,650 d post injection, upon which the bones were disarticulated and freed of soft tissues with sharp blades. The skeletal parts were ashed and analyzed for their strontium content (Durbin et al. 1993a and b) .
In order to use the above data for biokinetic model construction and verification, it was important that corrections were made for material loss. All collection data were therefore normalized to 100% recovery.
BIOKINETIC MODELS
The International Commission on Radiological Protection (ICRP) and the National Council on Radiation Protection and Measurements (NCRP) have developed and recommended various biokinetic models that can be used to describe the translocation of radioactive material inside the body. Such biokinetic models may be either pre-systemic models, which represent the behavior of radionuclides after entering the body via an intake pathway, or systemic models, which describe the translocation of radionuclides after their uptake into the blood.
The NCRP developed a biokinetic model for exposure to radioactive materials via contaminated wounds (NCRP 2006) . This model was largely based on experimental animal data due to the lack of human data not confounded from medical treatments or other forms of intake. The NCRP report proposes a multi-compartmental model comprised of five compartments that describe wound-site retention, systemic uptake into the blood or clearance into the lymph nodes.
The NCRP wound model can be coupled with the systemic model to describe the behavior of a radionuclide after intake via the wound pathway. The currently recommended systemic model for strontium is described in ICRP Publications 67 and 78 (ICRP 1993 and 1997 ). In the model, blood is treated as a uniformly mixed pool that connects with the soft tissues, skeleton, gastrointestinal tract and urinary bladder, each of which are represented by one or more compartments. The transfer of activity between the compartments is characterized by first-order kinetics, and the transfer rates between the compartments are given in the ICRP publications.
Since intramuscular injections are thought to simulate deep puncture wounds (NCRP 2006) , the biokinetic data from the intramuscularly injected NHPs can be evaluated by combining the NCRP 156 wound model with the ICRP 67 systemic model and the ICRP 100 human alimentary tract model (Fig. 1) . Because strontium is categorized as a "weakly retained soluble" radionuclide in the NCRP 156 report, Fig. 1 represents the wound model for soluble radionuclides, and the transfer rates between the wound compartments in Table 2 represent those for weakly retained radionuclides given in NCRP Report 156. The compartmental calculations were completed using a method described by Birchall and James (1989) . This method involves starting with a rate matrix [R], as seen in Table 2 . The rate matrix [R] is then converted into matrix [A] by replacing the diagonal elements of each row of [R] with the negative of the sum of the transfer rates in that row and the decay constant, and then transposing the matrix. The [A] matrix can then be used to calculate the quantities in each compartment at time t:
If x(0) is the column vector representing the initial amount in each compartment, the instantaneous amount in each compartment at time t, x(t) is then given as:
A simple code in Python® was written to solve the wound model coupled with the systemic model and calculate the urinary and fecal excretion, as well as activities in blood and skeletal compartments. The compartmental calculations were verified using Activity and Internal Dose Estimates (AIDE) (Bertelli et al. 2008 ).
PLASMA RETENTION AND CLEARANCE
Blood samples are rarely taken in the case of radioactive material exposure, and they are almost never used for intake or dose assessment. Nevertheless, the time-dependent activities in plasma are useful for biokinetic model comparison and development. The concentration of strontium in total plasma was calculated from the percentage of injected activity (%ID) in a blood sample as: 
where 36.4 mL kg −1 is the volume of plasma per body weight; 0.56 is the whole-body hematocrit in rhesus monkeys as measured by Gregersen et al. (1959) ; and 1.058 g mL −1 is the density of whole blood assumed to be the same as for the ICRP 23 Reference Man (ICRP 1974) .
The predictions of "weakly retained" NCRP 156 wound models combined with the ICRP 67 Sr systemic model were Feces compared against the composited plasma retention data from the NHP population (Fig. 2 ). Comparisons were also made against the predictions of the ICRP 67 systemic model alone (assuming direct input into the blood). As seen in the figure, the actual measured values in NHPs are consistently lower than those predicted by the human models. The NCRP 156 model coupled with the ICRP 67 systemic model predicts that the activity in plasma would reach a maximum within about 45 min of wound intake. It is hard to tell when exactly the plasma retention in NHPs after an intake via i.m. injection reached the maximum because the earliest sampling time was an hour after intake, at which point the activity in plasma had already started to decline. Early plasma retention values (before they reached a maximum) and the retention data in i.m. sites would have been useful to parameterize the wound model. Unfortunately, the i.m. retention measurements were not taken since strontium was known to clear rapidly into the blood because of its high solubility. The urinary excretion of 90 Sr from the NHPs was also compared against the predictions of the biokinetic models for humans (Fig. 3) . It is apparent from the figure that the excretion of strontium at times immediately after injection in NHPs is much greater than that in humans. For example, the excretion of strontium the day after intake via intramuscular injection was 45.37 ± 8.41% in the NHPs compared to only 17.85% in humans (as predicted by NCRP 156 wound model + ICRP 67 systemic model). The differences can possibly be attributed to the contents of the diet of the animals. The animals discussed in this paper were fed a high calcium diet-0.03-0.12 g d −1 kg −1 body weight (Durbin et al. 1973) . For comparison, the recommended dietary calcium intake for 15-59-y-old adult humans is 1,000 mg (roughly 0.014 g d −1 kg −1 body weight) (NIH 2016). The effect of dietary calcium on strontium metabolism was recognized early by the health physics community (ICRP 1972) . Early animal studies on strontium metabolism have reported the effect of calcium on strontium metabolism in humans and animals, particularly on urinary excretion. In a study by Kidman et al. (1950) , the total excretion of 90 Sr 9 d post intake for rabbits on a "low" calcium diet was 5.6% compared to 57.2% and 68.8% for those on a "medium" and "high" calcium diet, respectively. Palmer et al. (1958) reported that variation in the calcium, phosphorous, carbonate, and lactate content of the diet resulted in nearly a sevenfold variation in strontium deposition in rats. Similarly, Spencer et al. (1961) studied the effect of the addition of calcium to the diet on strontium metabolism in humans and concluded that a high calcium diet was associated with higher excretion of strontium in patients who received intravenous doses of 85 Sr. Since strontium is less completely bound to protein than is calcium (Samachson and Lederer 1958) , it is preferentially filtered at a much higher rate in kidneys (Comar et al. 1957) .
Fecal excretion in NHPs was found to be in relatively better agreement with humans. This was consistent with the observations of Kidman et al. (1950) in rabbits. For at least the first week after intake, diet appears to make a smaller difference to the amount excreted in the feces than in the urine (Fig. 3) . The ratio of cumulative urine to fecal excretion for 14 d after the intake was 7.07 ± 1.74. This was significantly larger than what has been measured in humans, which ranges from approximately 2.8 to 4.0 in different human studies for 12 to 18 d post intake (Spencer et al. 1960; Newton et al. 1990 ). The ICRP, in its biokinetic model, assumed this ratio to be 3.3 (ICRP 1993). The average excretion of strontium in both the urine and the feces in NHPs also seemed to fall below that for humans after a few days post intake (Fig. 3) . This was because almost 55% of the injected strontium was excreted via urine in the first 2 d, leaving less strontium in blood available for filtration by kidneys or transfer into the gastrointestinal tract. The cumulative urinary excretion in the NHPs was 70.07 ± 9.96 % of injected activity in 14 d (compared to approximately 49% as predicted by the ICRP model).
The activities retained in the NHP skeleton at the time of death were also compared against the predictions of the human biokinetic models (Fig. 4) . The retention in NHP skeleton was lower for the majority of the animals compared to the humans. For example, the skeletal retention in animals sacrificed at 8 and 5,650 d after intake was 14.3% and 0.77% of the injected activity, compared to approximately 20% and 3%, respectively, in humans. This difference was expected because the whole-body retention in the NHPs was affected by the larger renal plasma clearance rate observed in NHPs.
It is important to point out the variability between the subjects despite all subjects being adult females of the same species. For example, the urinary and fecal excretions on the first day after injection ranged from 33.9% to 56.7% and 0.26% to 4.37% of the injected activity, respectively. These differences may be a result of differences in diet; however, it is hard to quantify the effect because the exact calcium contents in the diets of individual animals were not recorded. The differences due to age or weight of the animals in this population of adult females, or those due to the injected amount or dosage, were not apparent or may have been obscured by the larger inter-animal variations. Such variations, even in the controlled experimental scenarios, allude to the difficulties in creating a biokinetic model valid for the entire population of animals (or humans).
CONCLUSION
The similarities in anatomy and patterns of growth and aging between the human and NHP skeleton have prompted several bone studies in monkeys. NHPs are also constantly being used to better understand postmenopausal osteoporosis (Brommage 2001) in human females because of the anatomical and physiological similarities of the reproductive systems. While NHPs, especially the Old World Macaques, are considered by several scientific disciplines to be an appropriate animal model for humans, the current analysis indicates differences in certain pathways. Moreover, care should be taken to ensure that the content of the diet of the experimental NHPs is similar to that of the humans to which they are being compared. These important details, along with the inter-animal variability, should be considered when estimating the behavior of strontium in humans from the metabolic data in animals.
